Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
22 March 2022 - 10:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March, 2022
Commission File Number: 001-37891
AC IMMUNE SA
(Exact name of registrant as specified in its charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
| |
AC IMMUNE SA
|
| |
|
| |
By:
|
/s/ Andrea Pfeifer
|
| |
|
Name:
|
Andrea Pfeifer
|
| |
|
Title:
|
Chief Executive Officer
|
| |
|
|
|
| |
|
|
By:
|
/s/ Joerg Hornstein
|
| |
|
|
|
Name:
|
Joerg Hornstein
|
| |
|
|
|
Title:
|
Chief Financial Officer
|
|
Date:
|
March 22, 2022
|
|
|
|
|
EXHIBIT INDEX
|
|
|
|
|
|
|
Press Release dated March 22, 2022
|
|
|
|
2021 IFRS Consolidated Financial Statements
|
|
|
|
2021 Statutory Annual Report
|
|
|
|
2021 Compensation Report
|
3
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2024 to Apr 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Apr 2023 to Apr 2024
